Comparative effectiveness of biguanides versus SGLT2 inhibitors on cardiovascular and cerebrovascular events, diabetic nephropathy, retinopathy, neuropathy, and treatment expenditures in patients with type 2 diabetes. - Nakatani, Eiji; Ohno, Hiromitsu; Nagahama, Takayoshi; Tonoike, Toru; Yui, Hiromichi; Satoh, Tatsunori; Matsunaga, Taku; Funaki, Daito; Ueki, Chikara; Ohata, Emi; Miyakoshi, Akinori; Igarashi, Ataru; et al. (PLoS ONE, 2025)